Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypo
📰
Sourced From
Google News – Japan
Read Full Article →

Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity  Yahoo Finance

Source: Google News – Japan — Read full article →


Content sourced from third parties. Copyright belongs to original publishers.


Leave a Reply

Your email address will not be published. Required fields are marked *